Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Axogen Inc

AXGN
18,21
-0,06 (-0,33%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202519:20EDGAR2Form 144 - Report of proposed sale of securities
14/1/202519:24EDGAR2Form 144 - Report of proposed sale of securities
10/1/202523:00GLOBEAxogen Announces New VP of Operations and Inducement Grant..
10/1/202514:01EDGAR2Form 8-K - Current report
10/1/202514:00GLOBEAxogen Reports Preliminary Unaudited Revenue for Fourth..
08/1/202522:35EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
07/1/202500:40EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
07/1/202500:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202421:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:34EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202416:52EDGAR2Form 144 - Report of proposed sale of securities
07/11/202413:08EDGAR2Form 8-K - Current report
07/11/202413:00GLOBEAxogen, Inc Reports Third Quarter 2024 Financial Results and..
24/10/202413:00GLOBEAxogen, Inc. to report third quarter 2024 financial results..
17/9/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/9/202413:09EDGAR2Form 8-K - Current report
06/9/202413:00GLOBEAxogen Completes Submission of Biologics License Application..
05/9/202422:33EDGAR2Form 144 - Report of proposed sale of securities
05/9/202403:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202413:00GLOBEAxogen Reports Inducement Grant to New Employee Under NASDAQ..
21/8/202422:31EDGAR2Form 144 - Report of proposed sale of securities
13/8/202423:00EDGAR2Form 144 - Report of proposed sale of securities
13/8/202422:18GLOBECytoSorbents Appoints Peter J. Mariani Chief Financial..
12/8/202416:59EDGAR2Form 144 - Report of proposed sale of securities
09/8/202422:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:05EDGAR2Form 8-K - Current report
08/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:14EDGAR2Form 8-K - Current report
08/8/202413:05GLOBEAxogen, Inc. Announces New Leadership Appointments
08/8/202413:00GLOBEAxogen, Inc. Reports Second Quarter 2024 Financial Results
23/7/202413:00GLOBEAxogen, Inc. to Report Second Quarter 2024 Financial Results..
01/7/202413:00GLOBECompany Reports Inducement Grants to Non-Executive New..
24/6/202413:00GLOBEAxogen, Inc Announces Full Launch of Avive+ Soft Tissue..
11/6/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 18,5399 Min: 18,16 Max: 18,74
Chiusura: 18,27

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network